Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 2
1957 3
1994 1
1997 1
2003 3
2004 2
2005 1
2010 1
2012 1
2014 2
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

16 results
Results by year
Filters applied: . Clear all
Page 1
Pharmacokinetics of mirabegron, a β3-adrenoceptor agonist for treatment of overactive bladder, in healthy Japanese male subjects: results from single- and multiple-dose studies.
Iitsuka H, Tokuno T, Amada Y, Matsushima H, Katashima M, Sawamoto T, Takusagawa S, van Gelderen M, Tanaka T, Miyahara H. Iitsuka H, et al. Among authors: amada y. Clin Drug Investig. 2014 Jan;34(1):27-35. doi: 10.1007/s40261-013-0146-1. Clin Drug Investig. 2014. PMID: 24178236 Free PMC article. Clinical Trial.
Effects of 2-[N-(4-chlorophenyl)-N-methylamino]-4H-pyrido[3.2-e]-1,3-thiazin-4-one (YM928), an orally active alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist, in models of generalized epileptic seizure in mice and rats.
Yamashita H, Ohno K, Amada Y, Hattori H, Ozawa-Funatsu Y, Toya T, Inami H, Shishikura J, Sakamoto S, Okada M, Yamaguchi T. Yamashita H, et al. Among authors: amada y. J Pharmacol Exp Ther. 2004 Jan;308(1):127-33. doi: 10.1124/jpet.103.058495. Epub 2003 Oct 20. J Pharmacol Exp Ther. 2004. PMID: 14569061
16 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page